Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 177

Sort by

Sort Order Select

Journal Articles

EZH2 oncogenic mutation disrupts germinal center B cell dynamics and promotes early lymphomagenic behaviors

Kibaek Choe, Chanhong Min, Ioannis Karagiannidis, Nikita Sivakumar, Chris Xu, Ari Melnick, Jude Phillip, Wendy Béguelin

Blood (2025) 146 (Supplement 1): 1479.

https://doi.org/10.1182/blood-2025-1479

Published: 2025

Journal Articles

A phase 1b trial of the EZH2 inhibitor tazemetostat combined with CAR T cell therapy in B cell lymphomas

Samuel Yamshon, Caitlin Gribbin, Yusuke Isshiki, Ioannis Karagiannidis, Sunjae Lee, Jizhi Yan, Gwynne Ozkan, Anna Alperovich, Barbara Ma, Christopher Hackett, Mateo Mejia-Saldarriaga, Daniel Choi, Selina Chen-Kiang, John Leonard, Ari Melnick, Juliet Barker, Giorgio Inghirami, Wendy Béguelin, Peter Martin

Blood (2025) 146 (Supplement 1): 1011.

https://doi.org/10.1182/blood-2025-1011

Published: 2025

Journal Articles

Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.

Blood (2025) 146 (Supplement 1): 5263.

https://doi.org/10.1182/blood-2025-5263

Published: 2025

Journal Articles

Primary central nervous system lymphoma reveals a pro-tumoral brain-specific myeloid landscape.

Subhashini Joshi, María Revuelta, Nahuel Zamponi, Khouloud Kouidri, Federico Ruiz Moreno, Giorgio Inghirami, Ari Melnick, Leandro Cerchietti

Blood (2025) 146 (Supplement 1): 145.

https://doi.org/10.1182/blood-2025-145

Published: 2025

Journal Articles

Arginine methylation on MSI2 drives resistance to PRMT1/5 inhibitors in lymphoma, controls translation and dictates cell fate

Blood (2025) 146 (Supplement 1): 141.

https://doi.org/10.1182/blood-2025-141

Published: 2025

Journal Articles

Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities

Blood (2025) 146 (Supplement 1): 140.

https://doi.org/10.1182/blood-2025-140

Published: 2025

Journal Articles

Sasp-driven immune evasion defines a novel African ancestry-associated DLBCL subtype with distinctive molecular and immune vulnerabilities

Blood (2025) 146 (Supplement 1): 3.

https://doi.org/10.1182/blood-2025-3

Published: 2025

Journal Articles

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and reed-stenberg cells reveals escape from NK cell recognition and an unfolded protein response

Mikhail Roshal, Isabella Kong, Wikum Dinalankara, Matthew Teater, Bhavneet Bhinder, Sakellarios Zairis, Joshua Brody, Sunita Park, Alexandra Kovach, Matthew Oberley, Megan Lim, Matthew Barth, Olivier Elemento, Ari Melnick, Raul Rabadan, Amy Chadburn, Luigi Marchionni, Lisa Roth, Ethel Cesarman

Blood (2025) 146 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2025-3538

Published: 2025

Journal Articles

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

Blood (2023) 141 (18): 2194–2205.

https://doi.org/10.1182/blood.2022018254

Published: 2023

Includes: Supplemental data

Journal Articles

DTX1 Controls Germinal Center B-Cell Development and Lymphomagenesis

Atish Kizhakeyil, Sreejoyee Ghosh, Estela Rojas-Neira, Qing Deng, Jared Henderson, Jordan Showell, Ari Melnick, Wendy Beguelin, Francisco Vega, Loretta J. Nastoupil, Michael R Green

Blood (2022) 140 (Supplement 1): 1700–1701.

https://doi.org/10.1182/blood-2022-167086

Published: 2022

Journal Articles

Simultaneous Inhibition of SIRT3 and Cholesterol Homeostasis Targets AML Stem Cells By Perturbing Fatty Acid β-Oxidation and Inducing Lipotoxicity

Blood (2022) 140 (Supplement 1): 104–106.

https://doi.org/10.1182/blood-2022-157794

Published: 2022

Journal Articles

Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in Lymphoma

Qing Deng, Cem Meydan, Priya Lakra, Darko Barisic, Christopher R Chin, Estela Rojas-Neira, Vida Ravanmehr, Jared Henderson, Panhong Gou, Nader Kim El-Mallawany, Carl Allen, Branko Cuglievan, Francisco Vega, Christopher E Mason, Ari Melnick, Michael R Green

Blood (2022) 140 (Supplement 1): 1690–1691.

https://doi.org/10.1182/blood-2022-166258

Published: 2022

Journal Articles

The Single-Cell Pathology Landscape of Diffuse Large B Cell Lymphoma

Dylan McNally, Andrew Lytle, Hiranmayi Ravichandran, Wayne Tam, Christian Steidl, David W. Scott, Ari Melnick, Olivier Elemento

Blood (2022) 140 (Supplement 1): 162–163.

https://doi.org/10.1182/blood-2022-169912

Published: 2022

Journal Articles

FGFR1 Is a Novel Therapeutic Target in Relapsed/Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)

Nicolas Di Siervi, Maria Victoria Revuelta, Maria Teresa Cacciapuoti, Nahuel Zamponi, Rossella Marullo, Ari Melnick, Giorgio Inghirami, Leandro Cerchietti

Blood (2022) 140 (Supplement 1): 1322.

https://doi.org/10.1182/blood-2022-169529

Published: 2022

Journal Articles

Sirtuin 3 Inhibition Targets AML Stem Cells through Perturbation of Fatty Acid Oxidation

Cristiana O'Brien, Jacob Berman, Rachel Culp-Hill, Julie Reisz, Tianyi Ling, Vincent Rondeau, Meng Li, Min Yang, Jun Young Hong, Hening Lin, Ari Melnick, Andrea Arruda, Mark D. Minden, Angelo D'Alessandro, Courtney L Jones

Blood (2021) 138 (Supplement 1): 2240.

https://doi.org/10.1182/blood-2021-148143

Published: 2021

Journal Articles

Single Cell ATAC Lineage Deconvolution Reveals Overlapping Subclones in Epigenetically Distinct AML Samples

Deepika Dilip, Richard Koche, Kamal Menghrajani, Ari Melnick, Olivier Elemento, Ross L. Levine, Jacob L Glass

Blood (2021) 138 (Supplement 1): 2381.

https://doi.org/10.1182/blood-2021-154517

Published: 2021

Journal Articles

High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II Study

Blood (2021) 138 (Supplement 1): 138.

https://doi.org/10.1182/blood-2021-145495

Published: 2021

Journal Articles

BTG1 Mutation Promotes Aggressive Lymphoma Development By Lowering the Threshold to MYC Activation and Generating "Super-Competitor" B Cells

Blood (2021) 138 (Supplement 1): 359.

https://doi.org/10.1182/blood-2021-149921

Published: 2021

Journal Articles

Allogeneic Transplantation in Fit Older Adults Is Feasible and Encouragingly Efficacious. Post Remission Data from the Prospective ECOG-ACRIN (E2906) Clinical Study

Yishai Ofran, Zhuoxin Sun, Jacob M. Rowe, David F. Claxton, Martin S. Tallman, Daniel A. Arber, Ari Melnick, Ross L. Levine, Elisabeth Paietta, John E. Godwin, Hillard M Lazarus, Selina M. Luger, James M. Foran, Mark R. Litzow

Blood (2021) 138 (Supplement 1): 413.

https://doi.org/10.1182/blood-2021-149356

Published: 2021

Journal Articles

A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments

Blood (2021) 138 (Supplement 1): 704.

https://doi.org/10.1182/blood-2021-153300

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

EZH2 oncogenic mutation disrupts germinal center B cell dynamics and promotes early lymphomagenic behaviors

A phase 1b trial of the EZH2 inhibitor tazemetostat combined with CAR T cell therapy in B cell lymphomas

Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.

Primary central nervous system lymphoma reveals a pro-tumoral brain-specific myeloid landscape.

Arginine methylation on MSI2 drives resistance to PRMT1/5 inhibitors in lymphoma, controls translation and dictates cell fate

Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities

Sasp-driven immune evasion defines a novel African ancestry-associated DLBCL subtype with distinctive molecular and immune vulnerabilities

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and reed-stenberg cells reveals escape from NK cell recognition and an unfolded protein response

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

DTX1 Controls Germinal Center B-Cell Development and Lymphomagenesis

Simultaneous Inhibition of SIRT3 and Cholesterol Homeostasis Targets AML Stem Cells By Perturbing Fatty Acid β-Oxidation and Inducing Lipotoxicity

Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in Lymphoma

The Single-Cell Pathology Landscape of Diffuse Large B Cell Lymphoma

FGFR1 Is a Novel Therapeutic Target in Relapsed/Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)

Sirtuin 3 Inhibition Targets AML Stem Cells through Perturbation of Fatty Acid Oxidation

Single Cell ATAC Lineage Deconvolution Reveals Overlapping Subclones in Epigenetically Distinct AML Samples

High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II Study

BTG1 Mutation Promotes Aggressive Lymphoma Development By Lowering the Threshold to MYC Activation and Generating "Super-Competitor" B Cells

Allogeneic Transplantation in Fit Older Adults Is Feasible and Encouragingly Efficacious. Post Remission Data from the Prospective ECOG-ACRIN (E2906) Clinical Study

A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only